{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:39:09Z","timestamp":1793691549904,"version":"4.5.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20191492"],"award-info":[{"award-number":["BK20191492"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["KY202207"],"award-info":[{"award-number":["KY202207"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07923-7","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:13:15Z","timestamp":1772075595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glibenclamide attenuates osteoarthritis by suppressing NLRP3 inflammasome activation in synovial macrophages through the MAPK pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Jinrong","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3602-3840","authenticated-orcid":false,"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"7923_CR1","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JW Bijlsma","year":"2011","unstructured":"Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115\u201326.","journal-title":"Lancet"},{"key":"7923_CR2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.joca.2025.08.015","volume":"33","author":"A Dell\u2019Isola","year":"2025","unstructured":"Dell\u2019Isola A, Recenti F, Giardulli B, Lawford BJ, Kiadaliri A. Osteoarthritis year in review 2025: Epidemiology and therapy. Osteoarthritis Cartilage. 2025;33:1300\u20136.","journal-title":"Osteoarthritis Cartilage"},{"key":"7923_CR3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.joca.2025.08.004","volume":"33","author":"TG Wilson","year":"2025","unstructured":"Wilson TG, Baghel M, Ali SA. Osteoarthritis year in review 2025: Genetics, genomics, and epigenetics. Osteoarthritis Cartilage. 2025;33:1293\u20139.","journal-title":"Osteoarthritis Cartilage"},{"key":"7923_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(24)02322-5","volume":"405","author":"M Kloppenburg","year":"2025","unstructured":"Kloppenburg M, Namane M, Cicuttini F. Osteoarthr Lancet. 2025;405:71\u201385.","journal-title":"Osteoarthr Lancet"},{"key":"7923_CR5","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.joca.2024.07.014","volume":"32","author":"A Courties","year":"2024","unstructured":"Courties A, Kouki I, Soliman N, Mathieu S, Sellam J. Osteoarthritis year in review 2024: Epidemiology and therapy. Osteoarthritis Cartilage. 2024;32:1397\u2013404.","journal-title":"Osteoarthritis Cartilage"},{"key":"7923_CR6","doi-asserted-by":"crossref","first-page":"n2321","DOI":"10.1136\/bmj.n2321","volume":"375","author":"BR da Costa","year":"2021","unstructured":"da Costa BR, et al. Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ. 2021;375:n2321.","journal-title":"BMJ"},{"key":"7923_CR7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-133-8-200010170-00016","volume":"133","author":"DT Felson","year":"2000","unstructured":"Felson DT, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133:635\u201346.","journal-title":"Ann Intern Med"},{"key":"7923_CR8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11926-000-0021-y","volume":"2","author":"MB Goldring","year":"2000","unstructured":"Goldring MB. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep. 2000;2:459\u201365.","journal-title":"Curr Rheumatol Rep"},{"key":"7923_CR9","doi-asserted-by":"crossref","unstructured":"Panichi V, Costantini S, Grasso M, Arciola CR, Dolzani P. Innate immunity and synovitis: key players in osteoarthritis progression. Int J Mol Sci. 2024;25.","DOI":"10.3390\/ijms252212082"},{"key":"7923_CR10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","volume":"6","author":"J Sellam","year":"2010","unstructured":"Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010;6:625\u201335.","journal-title":"Nat Rev Rheumatol"},{"key":"7923_CR11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.joca.2019.12.007","volume":"28","author":"CL Wu","year":"2020","unstructured":"Wu CL, Harasymowicz NS, Klimak MA, Collins KH, Guilak F. The role of macrophages in osteoarthritis and cartilage repair. Osteoarthritis Cartilage. 2020;28:544\u201354.","journal-title":"Osteoarthritis Cartilage"},{"key":"7923_CR12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.joca.2020.01.007","volume":"28","author":"H Zhang","year":"2020","unstructured":"Zhang H, Cai D, Bai X. Macrophages regulate the progression of osteoarthritis. Osteoarthritis Cartilage. 2020;28:555\u201361.","journal-title":"Osteoarthritis Cartilage"},{"key":"7923_CR13","doi-asserted-by":"crossref","first-page":"1352946","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, Zhao F, Cheng H, Su M, Wang Y. Macrophage polarization: an important role in inflammatory diseases. Front Immunol. 2024;15:1352946.","journal-title":"Front Immunol"},{"key":"7923_CR14","doi-asserted-by":"crossref","unstructured":"Kuppa SS, Kim HK, Kang JY, Lee SC, Seon JK. Role of mesenchymal stem cells and their paracrine mediators in macrophage polarization: an approach to reduce inflammation in osteoarthritis. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms232113016"},{"key":"7923_CR15","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2018-213450","volume":"77","author":"H Zhang","year":"2018","unstructured":"Zhang H, et al. Synovial macrophage M1 polarisation exacerbates experimental osteoarthritis partially through R-spondin-2. Ann Rheum Dis. 2018;77:1524\u201334.","journal-title":"Ann Rheum Dis"},{"key":"7923_CR16","doi-asserted-by":"crossref","first-page":"e2307338","DOI":"10.1002\/advs.202307338","volume":"11","author":"B Liu","year":"2024","unstructured":"Liu B, et al. Inflammatory Fibroblast-Like Synoviocyte-Derived Exosomes Aggravate Osteoarthritis via Enhancing Macrophage Glycolysis. Adv Sci (Weinh). 2024;11:e2307338.","journal-title":"Adv Sci (Weinh)"},{"key":"7923_CR17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He Y, Hara H, Nunez G. Mechanism and Regulation of NLRP3 Inflammasome Activation. Trends Biochem Sci. 2016;41:1012\u201321.","journal-title":"Trends Biochem Sci"},{"key":"7923_CR18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/jcpe.13258","volume":"47","author":"J Zhang","year":"2020","unstructured":"Zhang J, et al. NLRP3 inflammasome mediates M1 macrophage polarization and IL-1beta production in inflammatory root resorption. J Clin Periodontol. 2020;47:451\u201360.","journal-title":"J Clin Periodontol"},{"key":"7923_CR19","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.it.2022.10.003","volume":"43","author":"A Olona","year":"2022","unstructured":"Olona A, Leishman S, Anand PK. The NLRP3 inflammasome: regulation by metabolic signals. Trends Immunol. 2022;43:978\u201389.","journal-title":"Trends Immunol"},{"key":"7923_CR20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou R, Yazdi AS, Menu P, Tschopp. J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2011;469:221\u20135.","journal-title":"Nature"},{"key":"7923_CR21","doi-asserted-by":"crossref","first-page":"114118","DOI":"10.1016\/j.biopha.2022.114118","volume":"158","author":"J Liu","year":"2023","unstructured":"Liu J, et al. Exercise induced meteorin-like protects chondrocytes against inflammation and pyroptosis in osteoarthritis by inhibiting PI3K\/Akt\/NF-kappaB and NLRP3\/caspase-1\/GSDMD signaling. Biomed Pharmacother. 2023;158:114118.","journal-title":"Biomed Pharmacother"},{"key":"7923_CR22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jare.2024.08.001","volume":"73","author":"P Zhang","year":"2025","unstructured":"Zhang P, et al. GDF11 protects against mitochondrial-dysfunction-dependent NLRP3 inflammasome activation to attenuate osteoarthritis. J Adv Res. 2025;73:501\u201315.","journal-title":"J Adv Res"},{"key":"7923_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jot.2024.04.004","volume":"46","author":"Y Fang","year":"2024","unstructured":"Fang Y, et al. Sipeimine ameliorates osteoarthritis progression by suppression of NLRP3 inflammasome-mediated pyroptosis through inhibition of PI3K\/AKT\/NF-kappaB pathway: An in vitro and in vivo study. J Orthop Translat. 2024;46:1\u201317.","journal-title":"J Orthop Translat"},{"key":"7923_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, et al. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6:263.","journal-title":"Signal Transduct Target Ther"},{"key":"7923_CR25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41392-022-01036-5","volume":"7","author":"Q Yuan","year":"2022","unstructured":"Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther. 2022;7:182.","journal-title":"Signal Transduct Target Ther"},{"key":"7923_CR26","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JS Arthur","year":"2013","unstructured":"Arthur JS, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013;13:679\u201392.","journal-title":"Nat Rev Immunol"},{"key":"7923_CR27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13075-021-02512-z","volume":"23","author":"J Lu","year":"2021","unstructured":"Lu J, et al. Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-kappaB pathways. Arthritis Res Ther. 2021;23:142.","journal-title":"Arthritis Res Ther"},{"key":"7923_CR28","doi-asserted-by":"crossref","first-page":"113589","DOI":"10.1016\/j.intimp.2024.113589","volume":"143","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, et al. Isoliensinine suppresses chondrocytes pyroptosis against osteoarthritis via the MAPK\/NF-kappaB signaling pathway. Int Immunopharmacol. 2024;143:113589.","journal-title":"Int Immunopharmacol"},{"key":"7923_CR29","doi-asserted-by":"crossref","unstructured":"Kim J, Lee H, Park S, et al. Donepezil regulates LPS and Abeta-stimulated neuroinflammation through MAPK\/NLRP3 inflammasome\/STAT3 signaling. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms221910637"},{"key":"7923_CR30","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7150\/ijbs.34211","volume":"15","author":"W Zhao","year":"2019","unstructured":"Zhao W, Ma L, Cai C, Gong X. Caffeine Inhibits NLRP3 Inflammasome Activation by Suppressing MAPK\/NF-kappaB and A2aR Signaling in LPS-Induced THP-1 Macrophages. Int J Biol Sci. 2019;15:1571\u201381.","journal-title":"Int J Biol Sci"},{"key":"7923_CR31","doi-asserted-by":"crossref","first-page":"h102","DOI":"10.1136\/bmj.h102","volume":"350","author":"M Balsells","year":"2015","unstructured":"Balsells M, et al. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015;350:h102.","journal-title":"BMJ"},{"key":"7923_CR32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/jcbfm.2008.120","volume":"29","author":"JM Simard","year":"2009","unstructured":"Simard JM, et al. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2009;29:317\u201330.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7923_CR33","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10753-014-9993-z","volume":"38","author":"W Cui","year":"2015","unstructured":"Cui W, et al. The antidiabetic agent glibenclamide protects airway hyperresponsiveness and inflammation in mice. Inflammation. 2015;38:835\u201345.","journal-title":"Inflammation"},{"key":"7923_CR34","doi-asserted-by":"crossref","unstructured":"Saresella M, Calabrese E, Marventano I, et al. Glibenclamide-loaded engineered nanovectors (GNVs) modulate autophagy and NLRP3-inflammasome activation. Pharmaceuticals (Basel). 2023;16.","DOI":"10.3390\/ph16121725"},{"key":"7923_CR35","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41401-021-00734-0","volume":"43","author":"N Cao","year":"2022","unstructured":"Cao N, et al. Glibenclamide alleviates beta adrenergic receptor activation-induced cardiac inflammation. Acta Pharmacol Sin. 2022;43:1243\u201350.","journal-title":"Acta Pharmacol Sin"},{"key":"7923_CR36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13287-022-03005-9","volume":"13","author":"H Zhou","year":"2022","unstructured":"Zhou H, et al. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate osteoarthritis of the knee in mice model by interacting with METTL3 to reduce m6A of NLRP3 in macrophage. Stem Cell Res Ther. 2022;13:322.","journal-title":"Stem Cell Res Ther"},{"key":"7923_CR37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/FBP.0000000000000599","volume":"32","author":"AF Rosado","year":"2021","unstructured":"Rosado AF, et al. Glibenclamide treatment prevents depressive-like behavior and memory impairment induced by chronic unpredictable stress in female mice. Behav Pharmacol. 2021;32:170\u201381.","journal-title":"Behav Pharmacol"},{"key":"7923_CR38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5582\/bst.2020.01029","volume":"14","author":"G Liu","year":"2020","unstructured":"Liu G, Chen X, Wang Q, Yuan L. NEK7: a potential therapy target for NLRP3-related diseases. Biosci Trends. 2020;14:74\u201382.","journal-title":"Biosci Trends"},{"key":"7923_CR39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"key":"7923_CR40","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ajhg.2023.06.010","volume":"110","author":"AL Arruda","year":"2023","unstructured":"Arruda AL, et al. Genetic underpinning of the comorbidity between type 2 diabetes and osteoarthritis. Am J Hum Genet. 2023;110:1304\u201318.","journal-title":"Am J Hum Genet"},{"key":"7923_CR41","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/annrheumdis-2019-216713","volume":"79","author":"J Li","year":"2020","unstructured":"Li J, et al. Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann Rheum Dis. 2020;79:635\u201345.","journal-title":"Ann Rheum Dis"},{"key":"7923_CR42","doi-asserted-by":"crossref","first-page":"907750","DOI":"10.3389\/fimmu.2022.907750","volume":"13","author":"U Nedunchezhiyan","year":"2022","unstructured":"Nedunchezhiyan U, et al. Obesity, Inflammation, and Immune System in Osteoarthritis. Front Immunol. 2022;13:907750.","journal-title":"Front Immunol"},{"key":"7923_CR43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.joca.2023.06.005","volume":"31","author":"A De Roover","year":"2023","unstructured":"De Roover A, Escribano-Nunez A, Monteagudo S, Lories R. Fundamentals of osteoarthritis: Inflammatory mediators in osteoarthritis. Osteoarthritis Cartilage. 2023;31:1303\u201311.","journal-title":"Osteoarthritis Cartilage"},{"key":"7923_CR44","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s12276-021-00697-6","volume":"53","author":"Q Li","year":"2021","unstructured":"Li Q, et al. Hyperglycemia-induced accumulation of advanced glycosylation end products in fibroblast-like synoviocytes promotes knee osteoarthritis. Exp Mol Med. 2021;53:1735\u201347.","journal-title":"Exp Mol Med"},{"key":"7923_CR45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/cmi.2015.95","volume":"13","author":"EK Jo","year":"2016","unstructured":"Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13:148\u201359.","journal-title":"Cell Mol Immunol"},{"key":"7923_CR46","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12964-023-01306-x","volume":"21","author":"H Galganska","year":"2023","unstructured":"Galganska H, Jarmuszkiewicz W, Galganski L. Carbon dioxide and MAPK signalling: towards therapy for inflammation. Cell Commun Signal. 2023;21:280.","journal-title":"Cell Commun Signal"},{"key":"7923_CR47","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2174\/1381612824666180327165604","volume":"24","author":"YT Yeung","year":"2018","unstructured":"Yeung YT, Aziz F, Guerrero-Castilla A, Arguelles S. Signaling Pathways in Inflammation and Anti-inflammatory Therapies. Curr Pharm Des. 2018;24:1449\u201384.","journal-title":"Curr Pharm Des"},{"key":"7923_CR48","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S1474-4422(24)00425-3","volume":"23","author":"KN Sheth","year":"2024","unstructured":"Sheth KN, et al. Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Neurol. 2024;23:1205\u201313.","journal-title":"Lancet Neurol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07923-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07923-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07923-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:02:37Z","timestamp":1774972957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07923-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7923"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07923-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental procedures were approved by the Animal Research Committee of Nanjing Medical University (Approval No. IACUC-2509035) and carried out in accordance with the Declaration of Helsinki. This study was approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University (Approval No: 2024-SRFA-211). All patients were informed prior to data collection and provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"We confirm that all the authors have reviewed and approved the final version of the manuscript and agreed to its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"454"}}